Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IW-1973 in Patients With Type 2 Diabetes With Albuminuria
NCT03217591Phase 2Completed
- Sponsor
- Akebia Therapeutics
- Start
- Aug 2017
- Primary completion
- Aug 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of praliciguat in diabetic nephropathy (DN), sponsored by Akebia Therapeutics. Started Aug 2017; status: completed.
02
Drugs
praliciguat
03
Conditions
diabetic nephropathy (DN)
Beyond the preview
Go deeper on NCT03217591.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03217591.